Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 42

1.

Rituximab in primary Sjögren's syndrome: a ten-year journey.

Carubbi F, Alunno A, Cipriani P, Bartoloni E, Ciccia F, Triolo G, Gerli R, Giacomelli R.

Lupus. 2014 Aug 5. pii: 0961203314546023. [Epub ahead of print]

PMID:
25096066
[PubMed - as supplied by publisher]
2.

In vitro immunomodulatory effects of microencapsulated umbilical cord Wharton jelly-derived mesenchymal stem cells in primary Sjögren's syndrome.

Alunno A, Montanucci P, Bistoni O, Basta G, Caterbi S, Pescara T, Pennoni I, Bini V, Bartoloni E, Gerli R, Calafiore R.

Rheumatology (Oxford). 2014 Jul 26. pii: keu292. [Epub ahead of print]

PMID:
25065014
[PubMed - as supplied by publisher]
3.

Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study.

Carubbi F, Alunno A, Cipriani P, Di Benedetto P, Ruscitti P, Berardicurti O, Bartoloni E, Bistoni O, Caterbi S, Ciccia F, Triolo G, Gerli R, Giacomelli R.

Semin Arthritis Rheum. 2014 May 15. pii: S0049-0172(14)00109-7. doi: 10.1016/j.semarthrit.2014.05.015. [Epub ahead of print]

PMID:
24935529
[PubMed - as supplied by publisher]
4.

The role of T helper 17 cell subsets in Sjögren's syndrome: similarities and differences between mouse model and humans.

Alunno A, Carubbi F, Caterbi S, Bistoni O, Bartoloni E, Giacomelli R, Gerli R.

Ann Rheum Dis. 2014 Jul;73(7):e42. doi: 10.1136/annrheumdis-2014-205517. Epub 2014 Mar 27. No abstract available.

PMID:
24675097
[PubMed - indexed for MEDLINE]
5.

Indoleamine 2,3-dioxygenase 1 (IDO1) is up-regulated in thyroid carcinoma and drives the development of an immunosuppressant tumor microenvironment.

Moretti S, Menicali E, Voce P, Morelli S, Cantarelli S, Sponziello M, Colella R, Fallarino F, Orabona C, Alunno A, de Biase D, Bini V, Mameli MG, Filetti S, Gerli R, Macchiarulo A, Melillo RM, Tallini G, Santoro M, Puccetti P, Avenia N, Puxeddu E.

J Clin Endocrinol Metab. 2014 May;99(5):E832-40. doi: 10.1210/jc.2013-3351. Epub 2014 Feb 11.

PMID:
24517146
[PubMed - indexed for MEDLINE]
6.

CD4(-)CD8(-) T-cells in primary Sjögren's syndrome: association with the extent of glandular involvement.

Alunno A, Carubbi F, Bistoni O, Caterbi S, Bartoloni E, Bigerna B, Pacini R, Beghelli D, Cipriani P, Giacomelli R, Gerli R.

J Autoimmun. 2014 Jun;51:38-43. doi: 10.1016/j.jaut.2014.01.030. Epub 2014 Jan 24.

PMID:
24461537
[PubMed - in process]
7.

Diagnosis and classification of autoimmune hypophysitis.

Falorni A, Minarelli V, Bartoloni E, Alunno A, Gerli R.

Autoimmun Rev. 2014 Apr-May;13(4-5):412-6. doi: 10.1016/j.autrev.2014.01.021. Epub 2014 Jan 13. Review.

PMID:
24434361
[PubMed - indexed for MEDLINE]
8.

Primary Sjogren's syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients.

Baldini C, Pepe P, Quartuccio L, Priori R, Bartoloni E, Alunno A, Gattamelata A, Maset M, Modesti M, Tavoni A, De Vita S, Gerli R, Valesini G, Bombardieri S.

Rheumatology (Oxford). 2014 May;53(5):839-44. doi: 10.1093/rheumatology/ket427. Epub 2013 Dec 24.

PMID:
24369420
[PubMed - indexed for MEDLINE]
9.

Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study.

Carubbi F, Cipriani P, Marrelli A, Benedetto P, Ruscitti P, Berardicurti O, Pantano I, Liakouli V, Alvaro S, Alunno A, Manzo A, Ciccia F, Gerli R, Triolo G, Giacomelli R.

Arthritis Res Ther. 2013 Oct 30;15(5):R172. doi: 10.1186/ar4359.

PMID:
24286296
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study.

Quartuccio L, Isola M, Baldini C, Priori R, Bartoloni Bocci E, Carubbi F, Maset M, Gregoraci G, Della Mea V, Salvin S, De Marchi G, Luciano N, Colafrancesco S, Alunno A, Giacomelli R, Gerli R, Valesini G, Bombardieri S, De Vita S.

J Autoimmun. 2014 Jun;51:75-80. doi: 10.1016/j.jaut.2013.10.002. Epub 2013 Nov 11.

PMID:
24231556
[PubMed - in process]
11.

IL-17-producing double-negative T cells are expanded in the peripheral blood, infiltrate the salivary gland and are partially resistant to corticosteroid therapy in patients with Sjögren's syndrome.

Alunno A, Bistoni O, Bartoloni Bocci E, Caterbi S, Bigerna B, Pucciarini A, Tabarrini A, Mannucci R, Beghelli D, Falini B, Gerli R.

Reumatismo. 2013 Oct 31;65(4):192-8. doi: 10.4081/reumatismo.2013.192.

PMID:
24192564
[PubMed - in process]
12.

Outcome of pregnancy in Italian patients with primary Sjögren syndrome.

Priori R, Gattamelata A, Modesti M, Colafrancesco S, Frisenda S, Minniti A, Framarino-dei-Malatesta M, Maset M, Quartuccio L, De Vita S, Bartoloni E, Alunno A, Gerli R, Strigini F, Baldini C, Tani C, Mosca M, Bombardieri S, Valesini G.

J Rheumatol. 2013 Jul;40(7):1143-7. doi: 10.3899/jrheum.121518. Epub 2013 Jun 1.

PMID:
23729805
[PubMed - indexed for MEDLINE]
13.

Characterization of a new regulatory CD4+ T cell subset in primary Sjögren's syndrome.

Alunno A, Petrillo MG, Nocentini G, Bistoni O, Bartoloni E, Caterbi S, Bianchini R, Baldini C, Nicoletti I, Riccardi C, Gerli R.

Rheumatology (Oxford). 2013 Aug;52(8):1387-96. doi: 10.1093/rheumatology/ket179. Epub 2013 May 14.

PMID:
23674818
[PubMed - indexed for MEDLINE]
14.

Large aortic pseudoaneurysm and subsequent spondylodiscitis as a complication of endovascular treatment of iliac arteries.

Faccenna F, Alunno A, Castiglione A, Carnevalini M, Venosi S, Gossetti B.

Thorac Cardiovasc Surg. 2013 Oct;61(7):606-9. doi: 10.1055/s-0033-1333843. Epub 2013 Apr 5.

PMID:
23564532
[PubMed - indexed for MEDLINE]
15.

Persistent type II endoleak: two cases of successful sacotomy.

Faccenna F, Alunno A, Castiglione A, Felli MM, Venosi S, Gattuso R, Gossetti B.

Ann Vasc Surg. 2013 Feb;27(2):240.e9-240.e11. doi: 10.1016/j.avsg.2012.06.011.

PMID:
23380561
[PubMed - indexed for MEDLINE]
16.

Anti-cyclic citrullinated peptide antibody titer predicts time to rheumatoid arthritis onset in patients with undifferentiated arthritis: results from a 2-year prospective study.

Bizzaro N, Bartoloni E, Morozzi G, Manganelli S, Riccieri V, Sabatini P, Filippini M, Tampoia M, Afeltra A, Sebastiani G, Alpini C, Bini V, Bistoni O, Alunno A, Gerli R; the Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA Group).

Arthritis Res Ther. 2013 Jan 22;15(1):R16.

PMID:
23339296
[PubMed - as supplied by publisher]
Free PMC Article
17.

The microbial capsular polysaccharide galactoxylomannan inhibits IL-17A production in circulating T cells from rheumatoid arthritis patients.

Pericolini E, Alunno A, Gabrielli E, Bartoloni E, Cenci E, Chow SK, Bistoni G, Casadevall A, Gerli R, Vecchiarelli A.

PLoS One. 2013;8(1):e53336. doi: 10.1371/journal.pone.0053336. Epub 2013 Jan 8.

PMID:
23308194
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Expansion of CD4+CD25-GITR+ regulatory T-cell subset in the peripheral blood of patients with primary Sjögren's syndrome: correlation with disease activity.

Alunno A, Nocentini G, Bistoni O, Petrillo MG, Bartoloni Bocci E, Ronchetti S, Lo Vaglio E, Riccardi C, Gerli R.

Reumatismo. 2012 Dec 11;64(5):293-8. doi: 10.4081/reumatismo.2012.293.

PMID:
23256104
[PubMed - indexed for MEDLINE]
19.

CEA versus CAS: short-term and mid-term results.

Felli MM, Alunno A, Castiglione A, Malaj A, Faccenna F, Jabbour J, Laurito A, Stavri D, Gossetti B.

Int Angiol. 2012 Oct;31(5):420-6.

PMID:
22990503
[PubMed - indexed for MEDLINE]
20.

IL-17-producing CD4-CD8- T cells are expanded in the peripheral blood, infiltrate salivary glands and are resistant to corticosteroids in patients with primary Sjogren's syndrome.

Alunno A, Bistoni O, Bartoloni E, Caterbi S, Bigerna B, Tabarrini A, Mannucci R, Falini B, Gerli R.

Ann Rheum Dis. 2013 Feb;72(2):286-92. doi: 10.1136/annrheumdis-2012-201511. Epub 2012 Aug 17.

PMID:
22904262
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk